
2.16BUSD
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US5907174016
CUSIP
590717104
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
June
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
4.46
Dividend Share
-
Dividend Yield
-
Earnings Share
-0.82
Wall Street Target Price
35.00
EPS Estimate Current Year
-0.46
EPS Estimate Next Year
-0.06
EPS Estimate Current Quarter
-0.07
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
65,384,000
Gross Profit TTM
-23,234,000
EBITDA
-64,339,000
Profit Margin
-144.33%
Return On Assets TTM
-6.16%
Return On Equity TTM
-18.22%
Revenue Per Share TTM
0.51
Qtly Revenue Growth YOY
1526.80%
Diluted Eps TTM
-0.82
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
454
Price Sales TTM
34.0982
Price Book MRQ
3.7576
Enterprise Value Revenue
31
Enterprise Value EBITDA
-6
221.93
3.05%1020.00
2.51%1058.90
1.20%31.33
1.06%129.08
0.46%267.59
0.38%120.00
0.00%141.01
-5.79%807.39
-0.94%545.01
-0.42%